Picture of DongKoo Bio & Pharma Co logo

006620 DongKoo Bio & Pharma Co Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m-7.21%
3m-4.06%
6m+0.44%
1yr-13.69%
Volume Change (%)
10d/3m-76.25%
Price vs... (%)
52w High-18.46%
50d MA-3.44%
200d MA-0.77%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital10.61%
Return on Equity6.55%
Operating Margin5.98%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total RevenueKR₩m104,837.39125,235.19139,215.81155,149.21194,987.76n/an/a14.03%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-66.69+233.79-38.39-29.54+2.27n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of DongKoo Bio & Pharma Co EPS forecast chart

Profile Summary

Dongkoo Bio&Pharma Co.,Ltd. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The major products include antihistamines, topical steroids, therapeutic agents for prostatitis, treatments for benign prostatic hyperplasia, atherosclerotic agents, and antibiotics, among others. The Company is involved in contract manufacturing organization business. It manufactures and sells therapeutic for osteoporosis, antiviral agents, erectile dysfunction treatments, hepatic disease agents; painkillers; gum treatments. In addition, the Company is engaged in the manufacturing and sale of medical devices and cosmetics. The Company distributes its products within the domestic market and to overseas markets, including America and Europe.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    July 1st, 1983
    Public Since
    February 13th, 2018
    No. of Shareholders
    20,453
    No. of Employees
    331
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    27,623,549

    006620 Share Price Performance

    Upcoming Events for 006620

    Q4 2023 DongKoo Bio & Pharma Co Ltd Earnings Release

    DongKoo Bio & Pharma Co Ltd Annual Shareholders Meeting

    Q1 2024 DongKoo Bio & Pharma Co Ltd Earnings Release

    Q2 2024 DongKoo Bio & Pharma Co Ltd Earnings Release

    Similar to 006620

    Picture of AbClon logo

    AbClon

    kr flag iconKorea Exchange - KOSDAQ

    Picture of ADBiotech Co logo

    ADBiotech Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Ahn-Gook Pharmaceutical Co logo

    Ahn-Gook Pharmaceutical Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Alteogen logo

    Alteogen

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Aminologics Co logo

    Aminologics Co

    kr flag iconKorea Exchange - KOSDAQ

    FAQ